Australia Stock Exchange release from NOXOPHARM : Veyonda Achieves Important U.S. Patent Claims
27/09/2021 24:57
Australia Stock Exchange release from NOXOPHARM NOX.AX : Veyonda Achieves Important U.S. Patent Claims
Recent news on Noxopharm
See all newsAustralia's Noxopharm hits three-month low on discounted placement
Brief: Noxopharm Receives Commitments For Placement
Brief: Noxopharm Requests Trading Halt Pending Material Capital Raising Announcement
Brief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential